Major shareholder announcement
June 21, 2024
Company announcement No. 22
Pursuant to Section 30 of the Danish Capital Markets Act, Novonesis hereby announces that Novo Nordisk Fonden has on its own behalf and on behalf of its wholly owned subsidiary Novo Holdings A/S notified Novonesis, that as of yesterday, Novo Nordisk Fonden and Novo Holdings A/S, indirectly and directly, respectively, holds a total of 53,743,600 A-shares (nominally DKK 107,487,200) and 65,672,555 B-shares (nominally DKK 131,345,110) corresponding to 25.50% of the entire issued share capital and 63.35% of the total voting rights in Novozymes A/S, part of Novonesis Group.
| Contact information | ||
| Tobias Bjorklund +45 3077 8682 [email protected] | ||
Anders Enevoldsen +45 5350 1453 [email protected] | ||
Disa Tuominen +45 6038 5826 [email protected] | ||
Attachment
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- reAlpha (NASDAQ: AIRE) Completes InstaMortgage Acquisition, Adding Direct Lending Capabilities to Company’s Integrated Platform
- Momcozy Launches DeepClean Bottle Washer (D8), Bringing Precision Cleaning to Breast Pump Parts and Small Feeding Accessories
- Springbig Completes Reorganization, Eliminating Approximately $12.5 Million of Secured Debt and Positioning SBIG to Explore Strategic Alternatives
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share